Filipino Healthcare Worker Recovers After Removal of Brain Tumor, Nearly the Size of a Tennis Ball, at Aster Hospital Mankhool
A 41-year-old Filipino woman, Ms. Jovelyn Sison Omes, a healthcare assistant at an aesthetic clinic in Dubai, underwent life-saving brain surgery at Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025. Ms. Omes had been experiencing severe headaches, nausea, double vision, and a full-body seizure – alarming symptoms that prompted immediate medical evaluation.
Upon her admission on November 27, 2024, scans revealed a large, non-cancerous brain tumor on the right side of her brain, known as a falcine meningioma. The tumor had grown across the center of her brain to the opposite side, causing swelling and pressure on critical brain areas, leading to a condition called cerebral edema and mass effect. Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, compared the tumor's size to that of a tennis ball.
Despite a medical history of asthma and high cholesterol, Ms. Omes was not on any regular medications. Her symptoms included persistent headaches (VAS 8/10), a seizure with tongue bite, temporary confusion, and a brief episode of double vision. She did not report limb weakness or trauma.
On November 28, 2024, Dr. Prakash Nair and his team performed a complex brain surgery on Ms. Jovelyn Sison Omes at Aster Hospital, Mankhool, to remove the tumor located near a critical brain region responsible for limb movement. The patient was placed under general anesthesia, and the surgical team accessed the tumor through four small openings in the skull.
Using advanced tools including a state-of-the-art microscope and ultrasonic aspirator (CUSA), the team performed a Simpson Grade 1 resection, meaning the tumor and its roots were entirely removed — significantly lowering the risk of recurrence. Bleeding was controlled without the need for transfusion, and the skull was reconstructed with precision.
Following surgery, Ms. Omes was transferred to the ICU and weaned off ventilator support within 24 hours. A follow-up scan confirmed complete tumor removal with no complications. She was mobilized the next day, resumed eating normally within hours, and responded well to physiotherapy. Discharged on December 5, 2024, she made a full recovery with no neurological issues.
'This case highlights the importance of timely diagnosis and advanced neurosurgical care. The tumor was located in a challenging area near vital brain structures, but we were able to remove it completely without causing any damage,' said Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, who led the surgery. He added, 'In cases of Simpson Grade 1 resection, the recurrence rate after 10 years is less than 9%2, which is extremely promising for the patient's long-term prognosis.'
Falcine meningiomas make up about 9% of all intracranial meningiomas1 and are more common in women, with a two- to three-fold higher occurrence than in men3. These tumors are typically diagnosed more often with increasing age. In this case, the tumor's fibroblastic subtype added to the complexity of the condition.
Ms. Jovelyn Sison Omes expressed her deep gratitude to Dr. Nair and the medical team, saying, 'I'm incredibly thankful to Dr. Nair and the entire team for saving my life. I had been suffering from debilitating symptoms, but today, I'm pain-free, seizure-free, and back to work. As a healthcare worker, I urge everyone not to ignore warning signs. Early intervention truly saved my life, and I hope my story encourages others to seek help when something doesn't feel right.
With follow-up imaging confirming a successful outcome and no neurological deficits, Ms. Omes is expected to lead a full and healthy life. Her case stands as a testament to the power of timely diagnosis, surgical expertise, and compassionate care — all hallmarks of Aster Hospital Mankhool's commitment to clinical excellence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
3 days ago
- Mid East Info
Filipino Healthcare Worker Recovers After Removal of Brain Tumor, Nearly the Size of a Tennis Ball, at Aster Hospital Mankhool
A 41-year-old Filipino woman, Ms. Jovelyn Sison Omes, a healthcare assistant at an aesthetic clinic in Dubai, underwent life-saving brain surgery at Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025. Ms. Omes had been experiencing severe headaches, nausea, double vision, and a full-body seizure – alarming symptoms that prompted immediate medical evaluation. Upon her admission on November 27, 2024, scans revealed a large, non-cancerous brain tumor on the right side of her brain, known as a falcine meningioma. The tumor had grown across the center of her brain to the opposite side, causing swelling and pressure on critical brain areas, leading to a condition called cerebral edema and mass effect. Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, compared the tumor's size to that of a tennis ball. Despite a medical history of asthma and high cholesterol, Ms. Omes was not on any regular medications. Her symptoms included persistent headaches (VAS 8/10), a seizure with tongue bite, temporary confusion, and a brief episode of double vision. She did not report limb weakness or trauma. On November 28, 2024, Dr. Prakash Nair and his team performed a complex brain surgery on Ms. Jovelyn Sison Omes at Aster Hospital, Mankhool, to remove the tumor located near a critical brain region responsible for limb movement. The patient was placed under general anesthesia, and the surgical team accessed the tumor through four small openings in the skull. Using advanced tools including a state-of-the-art microscope and ultrasonic aspirator (CUSA), the team performed a Simpson Grade 1 resection, meaning the tumor and its roots were entirely removed — significantly lowering the risk of recurrence. Bleeding was controlled without the need for transfusion, and the skull was reconstructed with precision. Following surgery, Ms. Omes was transferred to the ICU and weaned off ventilator support within 24 hours. A follow-up scan confirmed complete tumor removal with no complications. She was mobilized the next day, resumed eating normally within hours, and responded well to physiotherapy. Discharged on December 5, 2024, she made a full recovery with no neurological issues. 'This case highlights the importance of timely diagnosis and advanced neurosurgical care. The tumor was located in a challenging area near vital brain structures, but we were able to remove it completely without causing any damage,' said Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, who led the surgery. He added, 'In cases of Simpson Grade 1 resection, the recurrence rate after 10 years is less than 9%2, which is extremely promising for the patient's long-term prognosis.' Falcine meningiomas make up about 9% of all intracranial meningiomas1 and are more common in women, with a two- to three-fold higher occurrence than in men3. These tumors are typically diagnosed more often with increasing age. In this case, the tumor's fibroblastic subtype added to the complexity of the condition. Ms. Jovelyn Sison Omes expressed her deep gratitude to Dr. Nair and the medical team, saying, 'I'm incredibly thankful to Dr. Nair and the entire team for saving my life. I had been suffering from debilitating symptoms, but today, I'm pain-free, seizure-free, and back to work. As a healthcare worker, I urge everyone not to ignore warning signs. Early intervention truly saved my life, and I hope my story encourages others to seek help when something doesn't feel right. With follow-up imaging confirming a successful outcome and no neurological deficits, Ms. Omes is expected to lead a full and healthy life. Her case stands as a testament to the power of timely diagnosis, surgical expertise, and compassionate care — all hallmarks of Aster Hospital Mankhool's commitment to clinical excellence.
Mid East Info
24-05-2025
- Mid East Info
AI Brain Implant at KFSHRC Offers Parkinson's Relief with 50% Less Medication Riyadh hospital pioneers AI-powered therapy that delivers real-time brain stimulation for chronic neurological disorders
Riyadh King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has successfully executed a groundbreaking procedure in the Middle East, implanting an advanced smart device within the brain to help manage chronic neurological disorders. This device monitors abnormal electrical activity and sends targeted electrical impulses to the affected regions, aiming to alleviate symptoms, decrease dependence on medication, and enhance patients' quality of life, independence, and health stability. This state-of-the-art innovation enables patients to better control neurological symptoms and potentially lower medication doses by as much as 50%, reducing side effects and improving daily activities- especially for those with Parkinson's disease, epilepsy, and movement disorders. The device's built-in artificial intelligence rapidly analyses brain signals to detect abnormal activity patterns and responds by providing targeted electrical stimulation to restore neural balance. This allows for highly accurate, adaptive treatment that adjusts to the patient's condition in real time without requiring continuous manual intervention from healthcare professionals. While benefits start to appear within the first few weeks post-implantation, achieving optimal results requires a fine-tuning period of one to three months, during which electrical responses are calibrated according to real-time brain signals collected by the device. The procedure utilises minimally invasive methods lasting only three to five hours, avoiding large surgical cuts. This approach lessens recovery time, minimises complications, and encourages a quicker return to everyday activities. This achievement highlights KFSHRC's ongoing progress in harnessing artificial intelligence and medical innovation to provide high-precision, specialised care, meet patient needs, and shape an advanced therapeutic model for the region and beyond. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
15-04-2025
- Mid East Info
Aster Hospital Mankhool Introduces Cutting-Edge Robotic Orthopedic Centre - Middle East Business News and Information
Aster Hospital Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, has launched its state-of-the-art Robotic Surgery Centre, marking a significant advancement in orthopedic care with the introduction of the ROSA® Robotic Knee Joint Replacement System. This cutting-edge robotic surgical assistant works alongside surgeons from pre-surgery planning through to the procedure itself, enhancing accuracy and reducing the risk of surgical errors in bone preparation and implant placement. As the first robotic surgery facility within Aster Hospitals in the UAE, this milestone underscores the hospital's commitment to providing world-class, technology-driven healthcare solutions. The Robotic Surgery Centre was officially inaugurated by Olympic boxing legend and former Rajya Sabha Member, Mary Kom, who lauded the hospital's commitment to innovation and patient-centric advancements in healthcare. Studies indicate that the global knee replacement market is projected to reach USD 17.35 billion by 20341, driven by an increasing aging population, osteoarthritis and rising patient demand for effective, long-lasting treatments. Robotic-assisted knee replacement surgery addresses the challenges of traditional procedures by offering greater precision, reducing recovery time, and improving implant longevity. ROSA® assists surgeons by generating a 3D model of the patient's knee using preoperative CT scans (rather than X-rays), enabling a highly personalized and accurate surgical approach. By providing real-time data and intraoperative feedback, the system ensures optimal implant positioning, reduces surgical errors, and enhances joint function. The robotic assistance allows for customized treatment plans tailored to each patient's unique anatomy, significantly improving overall results. Commenting on the launch, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said 'At Aster, we are committed to continuously innovating and adopting advanced technologies that improve patient outcomes. The introduction of the robotic knee joint replacement system at Aster Hospital Mankhool is a testament to our vision of making high-quality, technology-driven healthcare accessible to our patients. With robotic-assisted surgery, we are bringing the future of orthopedic care to the region, ensuring more precision, faster recovery, and better overall experiences for patients undergoing knee replacement procedures.' The adoption of robotic-assisted knee replacement surgery at Aster Hospital Mankhool includes both knee and hip replacement surgeries, bringing multiple advantages over traditional procedures. Patients benefit from smaller incisions, minimal tissue disruption, and a reduced risk of complications, such as infections and nerve damage. The advanced technology enhances joint stability, ensuring proper alignment and lowering the risk of misalignment-related issues. Moreover, the precision of robotic assistance leads to improved implant longevity, potentially extending the lifespan of the prosthetic knee. Dr. Ranjith Narayan, Specialist Orthopaedics, Aster Hospital Mankhool, added, 'The introduction of the ROSA® Robotic Knee Joint Replacement System at Aster Hospital Mankhool is a game-changer in orthopedic care. This advanced robotic system enhances surgical precision by utilizing real-time data and 3D modeling, allowing for a highly personalized approach tailored to each patient's unique anatomy. By ensuring optimal implant positioning and minimizing surgical errors, the technology significantly improves joint function, reduces recovery time, and enhances overall patient outcomes. With robotic-assisted surgery, we are not only elevating the standard of knee replacement procedures but also providing our patients with a safer, more effective, and long-lasting treatment solution.' With reduced postoperative pain and a faster rehabilitation process, patients can expect shorter hospital stays and quicker recovery times. The minimally invasive nature of robotic-assisted surgery also reduces blood loss and promotes faster healing, contributing to an improved quality of life for individuals undergoing both knee and hip replacement surgeries. This technology is particularly beneficial for patients with severe arthritis or complex anatomical structures, offering them an advanced surgical solution for enhanced mobility and long-term joint health. With this introduction, Aster Hospital Mankhool reaffirms its commitment to integrating innovation and excellence into patient care. This launch represents a transformative step forward in orthopedic treatment, ensuring that patients receive the most precise, effective, and minimally invasive surgical interventions available.
